Vakulenko S B, Taibi-Tronche P, Tóth M, Massova I, Lerner S A, Mobashery S
Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
J Biol Chem. 1999 Aug 13;274(33):23052-60. doi: 10.1074/jbc.274.33.23052.
We investigated the effects of mutations at positions 164 and 179 of the TEM(pUC19) beta-lactamase on turnover of substrates. The direct consequence of some mutations at these sites is that clinically important expanded-spectrum beta-lactams, such as third-generation cephalosporins, which are normally exceedingly poor substrates for class A beta-lactamases, bind the active site of these mutant enzymes more favorably. We employed site-saturation mutagenesis at both positions 164 and 179 to identify mutant variants of the parental enzyme that conferred resistance to expanded-spectrum beta-lactams by their enhanced ability to turn over these antibiotic substrates. Four of these mutant variants, Arg(164) --> Asn, Arg(164) --> Ser, Asp(179) --> Asn, and Asp(179) --> Gly, were purified and the details of their catalytic properties were examined in a series of biochemical and kinetic experiments. The effects on the kinetic parameters were such that either activity with the expanded-spectrum beta-lactams remained unchanged or, in some cases, the activity was enhanced. The affinity of the enzyme for these poorer substrates (as defined by the dissociation constant, K(s)) invariably increased. Computation of the microscopic rate constants (k(2) and k(3)) for turnover of these poorer substrates indicated either that the rate-limiting step in turnover was the deacylation step (governed by k(3)) or that neither the acylation nor deacylation became the sole rate-limiting step. In a few instances, the rate constants for both the acylation (k(2)) and deacylation (k(3)) of the extended-spectrum beta-lactamase were enhanced. These results were investigated further by molecular modeling experiments, using the crystal structure of the TEM(pUC19) beta-lactamase. Our results indicated that severe steric interactions between the large 7beta functionalities of the expanded-spectrum beta-lactams and the Omega-loop secondary structural element near the active site were at the root of the low affinity by the enzyme for these substrates. These conclusions were consistent with the proposal that the aforementioned mutations would enlarge the active site, and hence improve affinity.
我们研究了TEM(pUC19)β-内酰胺酶164位和179位的突变对底物周转的影响。这些位点某些突变的直接后果是,临床上重要的超广谱β-内酰胺类抗生素,如第三代头孢菌素,它们通常是A类β-内酰胺酶的极差底物,却能更有利地结合这些突变酶的活性位点。我们在164位和179位都采用了位点饱和诱变,以鉴定亲本酶的突变变体,这些变体通过增强其周转这些抗生素底物的能力而赋予对超广谱β-内酰胺类抗生素的抗性。纯化了其中四个突变变体,即Arg(164)→Asn、Arg(164)→Ser、Asp(179)→Asn和Asp(179)→Gly,并在一系列生化和动力学实验中研究了它们催化特性的细节。对动力学参数的影响是,超广谱β-内酰胺类抗生素的活性要么保持不变,要么在某些情况下活性增强。酶对这些较差底物的亲和力(由解离常数K(s)定义)总是增加。计算这些较差底物周转的微观速率常数(k(2)和k(3))表明,周转中的限速步骤要么是脱酰基步骤(由k(3)控制),要么酰化和脱酰化都不是唯一的限速步骤。在少数情况下,超广谱β-内酰胺酶的酰化(k(2))和脱酰化(k(3))速率常数都增加了。利用TEM(pUC19)β-内酰胺酶的晶体结构,通过分子模拟实验进一步研究了这些结果。我们的结果表明,超广谱β-内酰胺类抗生素的大7β官能团与活性位点附近的Ω-环二级结构元件之间的严重空间相互作用是酶对这些底物低亲和力的根源。这些结论与上述突变会扩大活性位点从而提高亲和力的提议一致。